All lobbying filings

VANTIVE US HEALTHCARE LLC

VANTIVE US HEALTHCARE LLC filed a Q3 report for VANTIVE US HEALTHCARE LLC on October 20, 2025.

Lobbying for VANTIVE US HEALTHCARE LLC · Medical Technology Manufacturing

All filings by VANTIVE US HEALTHCARE LLC · Everything VANTIVE US HEALTHCARE LLC has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Expenses

$590,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 8

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Medicare/Medicaid

Issues related to ESRD reimbursement Issues related to telehealth reimbursement for remote patient monitoring Issues related to sepsis device breakthrough designation, including H.R. 4441 - Patient Access to Innovative New Technologies Act

Health Issues

Issues related to ESRD reimbursement Issues related to telehealth reimbursement for remote patient monitoring

Foreign Relations

Issues related to U.S. global assistance programs.

Trade (domestic/foreign)

Issues related to tariffs. Reaching out to establish contacts with US embassy teams in certain countries.

Bills named in this filing 1

H.R. 4441
Patient Access to Innovative New Technologies Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.